sabato, 2 maggio 2026

Notizie AIOM – anno XVIII

20 Dicembre 2019

ASTRO Issues Clinical Guideline on Radiation Therapy for Basal Cell and Cutaneous Squamous Cell Carcinomas

December 18, 2019 - A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients diagnosed with the most common types of skin cancers. The guideline details when radiation treatments ...
Leggi tutto

20 Dicembre 2019

ASCO Applauds Congress for Raising Minimum Age to Purchase Tobacco and Boosting Cancer Research Funding

December 19, 2019 - "The American Society of Clinical Oncology (ASCO) applauds Congress for working across party lines to raise the minimum age for purchasing tobacco products to 21. A longtime advocate on this issue, ASCO believes this important change will delay and reduce ...
Leggi tutto

20 Dicembre 2019

FDA Approval Sought for Lurbinectedin in Small Cell Lung Cancer

December 17, 2019 - A new drug application (NDA) has been submitted to the FDA seeking an accelerated approval for lurbinectedin for use as a second-line treatment for patients with small cell lung cancer (SCLC), according to PharmaMar, the manufacturer of the investigational ...
Leggi tutto

20 Dicembre 2019

FDA Approval Sought for Belantamab Mafodotin in Relapsed/Refractory Myeloma

December 17, 2019 - A biologics license application (BLA) has been filed with the FDA for belantamab mafodotin (GSK2857916) for the treatment of patients with relapsed or refractory multiple myeloma whose prior therapy included an immunomodulatory drug (IMiD), a proteasome ...
Leggi tutto

20 Dicembre 2019

FDA Grants Tucatinib Breakthrough Designation for HER2+ Breast Cancer

December 18, 2019 - The FDA has granted tucatinib a breakthrough therapy designation for use in combination with trastuzumab and capecitabine for the treatment of patients with unresectable locally advanced or metastatic HER2-positive breast cancer, including patients with ...
Leggi tutto

20 Dicembre 2019

4-year overview of pharmacovigilance activities in the EU shows robust and effective medicines safety system

December 17, 2019 - A report on the activities ensuring the safety of medicines carried out by EMA and the national competent authorities of the European Union (EU) Member States, Norway and Iceland from 2015 to 2018 shows that the EU pharmacovigilance system is strong and ...
Leggi tutto

20 Dicembre 2019

Launch of international pilot programme on inspection of manufacturers of sterile medicines

December 17, 2019 - EMA and its European and international partners are launching a pilot programme to increase their cooperation in the inspection of manufacturers of sterile medicines for human use. This new initiative is built on the success of and experience gained from ...
Leggi tutto

20 Dicembre 2019

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Abiraterone acetate plus prednisone and enzalutamide are both used for the treatment of metastatic castration-resistant prostate cancer. We aimed to determine the best sequence in which to use both drugs, as well as their second-line efficacy. In this multicentre, randomised, ...
Leggi tutto

20 Dicembre 2019

20 dicembre 2019 – Attivazione web e pubblicazione schede di monitoraggio – Registro Nivolumab (Bristol-Myers Squibb) (melanoma adiuvante)

20 Dicembre 2019

Giants of Cancer Care Inductee Announced as Next ASCO President

December 19, 2019 - Everett E. Vokes, MD, FASCO, who is a Giants of Cancer Care® recipient for Head and Neck Cancer, has been named the next president of ASCO for the 2021 to 2022 term. Additionally, Vokes, who is the John E. Ultmann Professor, chair of the Department ...
Leggi tutto